ArticleAnnals of medicine and surgery (2012)2025
Dermatomyositis associated with gestational trophoblastic neoplasia: a case report.
Article in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction and Importance: Dermatomyositis (DM) is an inflammatory myopathy with a known association with malignancies. The spectrum of associated cancers varies by age and geography, commonly including ovarian, lung, and breast cancers. However, its link with gestational trophoblastic neoplasia (GTN) has not been previously reported. Case Presentation: A 45-year-old woman with recently treated GTN presented with proximal muscle weakness, a facial rash, and elevated muscle enzymes. She was diagnosed clinically with DM and responded well to corticosteroids and methotrexate. Clinical Discussion: DM can occur before, during, or after cancer diagnosis. This rare case of DM following GTN supports the theory of immune cross-reactivity between tumor and muscle antigens. Diagnosis may rely on clinical criteria in resource-limited settings. Conclusion: In patients with cancer who present with cutaneous manifestations and muscle symptoms, DM should be considered, irrespective of the cancer type or treatment status.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.